https://scholars.lib.ntu.edu.tw/handle/123456789/544358
標題: | XRCC1 Polymorphisms and urinary 8-hydroxydeoxyguanine levels are associated with urothelial carcinoma | 作者: | Chiang C.-I. Huang Y.-L. CHAO-YUAN HUANG Shiue H.-S. Chen W.-J. YEONG-SHIAU PU Lin Y.-C. Hsueh Y.-M. |
公開日期: | 2015 | 出版社: | Public Library of Science | 卷: | 10 | 期: | 5 | 起(迄)頁: | e0124066 | 來源出版物: | PLoS ONE | 摘要: | The aim of this study was to examine the associations between the combined effects of urinary 8-Hydroxydeoxyguanine (8-OHdG) level and polymorphisms of XRCC1 Arg194Trp and XRCC1 Arg399Gln on the risk of urothelial carcinoma (UC). We conducted a hospitalbased case-control study that included 168 cases of UC and 336 age- and gender-matched healthy controls. We used polymerase chain reaction and restriction fragment length polymorphism analyses to examine the genotypes of XRCC1 Arg194Trp and XRCC1 Arg399Gln. We used a competitive in vitro enzyme-linked immunosorbent assay to determine urinary 8-OHdG levels. The XRCC1 399 Gln/Gln genotype and the XRCC1194 Arg/ Arg genotype were positively correlated to UC (OR [95%CI] = 2.27 [1.20-4.27] and 1.59 [1.06 -2.36], respectively). Urinary 8-OHdG levels were associated with UC in a dose-dependent manner. Participants with the XRCC1 (Arg399Gln) Gln/Gln genotype or the G-C/AC haplotype of XRCC1 and a high urinary 8-OHdG level had a significantly higher risk of UC than those with the Arg/Arg + Arg/Gln genotype or the G-T haplotype and a low urinary 8- OHdG level. This is the first study to investigate the combined effect of urinary 8-OHdG level and XRCC1 polymorphisms on UC risk. The findings are especially meaningful for participants with XRCC1 399Gln or XRCC1 Arg194 genotypes and a high urinary 8-OHdG level, since these variables are associated with an increased risk of UC. ? 2015 Chiang et al. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929093473&doi=10.1371%2fjournal.pone.0124066&partnerID=40&md5=87a6260cee4e8473e0cfb6c12332b985 https://scholars.lib.ntu.edu.tw/handle/123456789/544358 |
ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0124066 | SDG/關鍵字: | 2 aminopurine; 8 hydroxydeoxyguanine; arsenic; unclassified drug; XRCC1 protein; 8-oxo-7,8-dihydrodeoxyguanine; DNA binding protein; guanine; X-ray repair cross complementing protein 1; adult; Article; cancer risk; case control study; controlled study; enzyme linked immunosorbent assay; female; genetic polymorphism; genotype; haplotype; human; major clinical study; male; polymerase chain reaction; questionnaire; restriction fragment length polymorphism; Taiwan; transitional cell carcinoma; XRCC1 gene; adverse effects; analogs and derivatives; cancer grading; cancer staging; demography; genetic predisposition; genetics; middle aged; pathology; risk factor; single nucleotide polymorphism; smoking; urinary tract tumor; urine; urothelium; Case-Control Studies; Demography; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Guanine; Haplotypes; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Urologic Neoplasms; Urothelium |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。